Understanding Resistance to Targeted Therapies in Oesophageal Squamous Cell Carcinoma as a Foundation to Developing New Precision Medicine Approaches

Petty, Russell (Investigator)

Molecular and Clinical Medicine

Project Details

Status	Active
Effective start/end date	1/03/20 → 1/12/22

Funding

(TCS/19/18): £373,449.00
Chief Scientist Office: £35,156.00

1 Article

Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed
Meemanage, M., Spender, L. C., Collinson, D., Iannetta, J., Challapalli, P., Turbitt, J., Clark, C., Baxter, M., Murray, G., Walsh, S., Miedzybrodzka, Z. & Petty, R. D., 9 Nov 2020, (E-pub ahead of print) In: Cancer Chemotherapy and Pharmacology. 17 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
12 Downloads (Pure)